ZBTB32

ZBTB32 (ROG/FAZF/TZFP) is a BTB-ZF transcriptional repressor that constrains lymphocyte proliferation and differentiation programs and contributes to gene control in non-immune tissues (PMID:10755619, PMID:24747678, PMID:28827827). It uses C-terminal zinc fingers for sequence-specific DNA binding—recognizing a defined TGTACAGTGT-type motif—while its N-terminal BTB/POZ domain carries repressor activity; crystallographic analysis showed this BTB domain forms an unusual non-domain-swapped dimer, distinguishing it from PLZF and related family members (PMID:11279021, PMID:20493880). ZBTB32 represses GATA-3-driven Th cytokine transactivation and physically engages GATA-2 through its zinc-finger region, and in CD8 T cells it binds the IL-13/IL-4 locus and recruits HDAC1 and HDAC2 to silence cytokine gene activation via histone deacetylation (PMID:10755619, PMID:11964310, PMID:12932361). As a direct NF-AT target, it acts as a negative regulator of NF-κB activity, limiting IL-2 and IL-12p40 production (PMID:15632058). Across lymphocyte lineages it functions as a proliferation/differentiation 'hub' acting through other transcriptional regulators: cytokine-induced ZBTB32 antagonizes the anti-proliferative factor Blimp-1 to enable virus-specific NK cell expansion, physically binds Blimp-1 to co-regulate Eomes and Cd27 in effector CD8+ T cells, restrains memory B cell recall responses, and competitively displaces Bcl6 at the Id2 locus to drive the terminally exhausted CD8+ T cell program in tumors (PMID:24747678, PMID:27357154, PMID:28827827, PMID:41649522). Beyond immunity, ZBTB32 represses piRNA cluster transcription and androgen receptor signaling in the testis and cooperates with the glucocorticoid receptor to drive adrenal Scarb1 expression required for cholesterol-dependent glucocorticoid synthesis during starvation (PMID:22965116, PMID:23634227, PMID:34337361).

1. 2000 Medium

   Established ZBTB32 as a transcriptional repressor by showing it binds GATA-3 and suppresses GATA-3-driven Th cytokine production, framing it as a brake on cytokine gene activation.

   Evidence Molecular cloning, co-IP, reporter transactivation assay, and overexpression in Th clones

   PMID:10755619

   Open questions at the time

   • Repression shown by overexpression; endogenous requirement not tested
   • DNA-binding motif not yet defined
2. 2001 High

   Defined the molecular grammar of ZBTB32 action by mapping a sequence-specific DNA-binding motif to the zinc fingers and localizing repressor activity to the BTB/POZ domain.

   Evidence EMSA, DNase I footprinting, competition, and VP16-fusion/mutagenesis reporter assays at the Aie1 promoter

   PMID:11279021

   Open questions at the time

   • Genome-wide target spectrum unknown
   • Corepressors mediating BTB repression not identified here
3. 2002 Medium

   Extended the GATA-targeting model and revealed lineage context by showing ZBTB32 binds GATA-2 via a distinct interface from PLZF and is expressed in CD34+ progenitors where it influences the cell cycle.

   Evidence Co-IP/domain mapping for GATA-2; immunofluorescence and inducible expression with cell-cycle/apoptosis readouts in myeloid cells

   PMID:11964310 PMID:11986317

   Open questions at the time

   • Functional consequence of GATA-2 binding not directly assayed
   • Cell-cycle effects shown by enforced expression only
4. 2003 Medium

   Identified the repression mechanism at a cytokine locus, showing ZBTB32 recruits HDAC1/2 to enforce CD8 T cell-specific silencing through histone deacetylation.

   Evidence ChIP for ZBTB32/HDAC1/HDAC2, histone acetylation analysis, and reporter assays at the IL-13/IL-4 locus

   PMID:12932361

   Open questions at the time

   • Direct HDAC1/2 physical interaction with ZBTB32 not isolated
   • Generality across other repressed loci untested
5. 2005 High

   Placed ZBTB32 in a signaling circuit by genetics, defining it as a direct NF-AT target that negatively regulates NF-κB and dampens T cell and dendritic cell cytokine output.

   Evidence Knockout mice, anti-CD3 stimulation, cytokine ELISA, NF-κB activity assays, in vivo Th differentiation

   PMID:15632058

   Open questions at the time

   • Molecular mechanism by which ZBTB32 suppresses NF-κB not resolved
   • Dispensable for Th1/Th2 differentiation, leaving primary in vivo role open
6. 2010 High

   Provided the structural basis for ZBTB32 dimerization, revealing a non-domain-swapped BTB dimer that distinguishes it from PLZF and predicts a smaller interface.

   Evidence 2.0 Å X-ray crystallography plus cysteine cross-linking in solution

   PMID:20493880

   Open questions at the time

   • Functional consequence of the non-swapped interface for corepressor recruitment unknown
   • No structure of zinc fingers bound to DNA
7. 2013 Medium

   Demonstrated tissue-specific repression in the testis, showing loss of ZBTB32 derepresses piRNA cluster 1082B and AR target genes with downstream transposon and apoptosis effects.

   Evidence Knockout mice, small RNA sequencing, binding-site identification, AR target gene and apoptosis analyses

   PMID:22965116 PMID:23634227

   Open questions at the time

   • Direct vs. indirect repression of AR signaling not fully separated
   • Mechanism linking ZBTB32 to piRNA processing machinery unknown
8. 2014 High

   Defined ZBTB32 as a cytokine-induced proliferation hub in NK cells acting upstream of Blimp-1, establishing its core immune logic of antagonizing an anti-proliferative factor.

   Evidence Knockout mice, viral infection model, cytokine stimulation, and genetic epistasis with Blimp-1/Prdm1

   PMID:24747678

   Open questions at the time

   • Direct molecular antagonism with Blimp-1 not biochemically resolved in this study
   • Target genes mediating the proliferative burst not enumerated
9. 2017 High

   Showed the Blimp-1 antagonism is a physical partnership in CD8+ T cells, where ZBTB32 binds Blimp-1 and co-regulates Eomes and Cd27 to balance effector versus memory and immunopathology.

   Evidence Knockout mice, viral infection, co-IP for ZBTB32–Blimp-1, and target gene analysis

   PMID:28827827

   Open questions at the time

   • Whether ZBTB32 acts as co-repressor or co-activator at shared loci not fully defined
   • Genome-wide ZBTB32/Blimp-1 co-occupancy not mapped
10. 2019 Medium

    Refined ZBTB32's B cell function as context-specific, restraining memory recall antibody responses during chronic infection but not acute challenge.

    Evidence Mixed bone marrow chimeras, chronic and acute infection models, antigen-specific ELISA

    PMID:27357154 PMID:31649328

    Open questions at the time

    • Molecular targets in memory B/plasma cells not identified
    • Basis for chronic- vs acute-specific requirement unknown
11. 2021 Medium

    Revealed a non-immune metabolic role by showing ZBTB32 is required for GR-driven adrenal Scarb1 expression and cholesterol-dependent glucocorticoid synthesis during starvation.

    Evidence Knockout mice, starvation protocol, glucocorticoid measurement, Scarb1 expression, metabolic phenotyping

    PMID:34337361

    Open questions at the time

    • Direct ZBTB32 binding at the Scarb1 locus not shown
    • Physical GR–ZBTB32 cooperation not biochemically demonstrated
12. 2026 Medium

    Extended the differentiation-control role to anti-tumor immunity, showing ZBTB32 competes with Bcl6 for DNA binding at Id2 to drive the terminally exhausted CD8+ T cell program.

    Evidence Tumor models, knockout/overexpression, CD28 perturbation, competitive DNA-binding assay vs. Bcl6 at Id2, cytotoxicity/proliferation assays

    PMID:41649522

    Open questions at the time

    • Competitive binding mechanism shown in one system
    • Whether ZBTB32 represses or activates Id2 net output not fully resolved

• How ZBTB32's distinct non-swapped BTB dimer selects corepressors and how it switches between repressing GATA/AR/piRNA loci and competing with Blimp-1/Bcl6 at lineage genes remains unresolved.
• No genome-wide ChIP defining the full direct target set
• Corepressor complex assembled on the BTB domain not identified
• No human disease link established in the corpus